News about our Companies - MedTech Innovator

GTT Group’s Patent Equity Fund Ideaship Invests in 8chili to Deploy Revolutionary Surgical Technology to Build the Foundation for Autonomous Surgeries

DateJan 14 2021

Ideaship, a patent leveraged venture capital firm that provides patent development support to early-stage startups, announced it has invested in 8chili, Inc. The investment will assist 8chili’s mission to reimagine surgical training and surgeries with 8chili’s patent pending device, NAVIX AIR.

Koya Medical Closes $11M Financing to Accelerate Treatment for Lymphedema and Venous Disorders

DateJan 14 2021

Koya Medical (www.koyamedical.com), a healthcare company focused on treating lymphedema and vein disease, today announced the close of a $11 million Series A investment round. The new investment was led by Arboretum Ventures.

Promaxo Raises $4.17M in Funding Round Led by Huami Corporation

DateJan 13 2021

. Promaxo’s patient-centric approach will provide patients with cutting-edge technology as it works to expand the frontiers of knowledge in the fields of medical imaging, robotics, and artificial intelligence.

Itamar Medical acquires Spry Health to improve remote sleep apnea treatment

DateJan 13 2021

Leading Israeli sleep apnea digital health company Itamar Medical has announced its acquisition of Spry Health in a bid to expand its product offerings into remote monitoring and support for the condition.

Novus Diagnostics gets €2.4M grant for rapid sepsis test

DateJan 12 2021

Irish company Novus Diagnostics has been awarded €2.4 million in funding to commercialise its rapid sepsis test. The only Irish company to be awarded funding from this round of the European Innovation Council (EIC) Accelerator pilot, DCU-based Novus Diagnostics has been working in collaboration with two Dublin hospitals on validating the SepTec diagnostic device.

NEUROFLOW closes $20M Series B Investment

DateJan 12 2021

NeuroFlow, the market leader in solutions supporting technology-enabled behavioral health integration, announces today the initial closing of a $20M Series B financing round led by Magellan Health (NASDAQ: MGLN), in addition to a syndicate including previous investors.

Rhaeos: Greater Insight for Hydrocephalus Solutions

DateJan 07 2021

The shunts that relieve fluid pressure in the brain are failure-prone, but current imaging methods don’t provide enough data to assess their function. Rhaeos is seeking to fill that gap with a wearable flow monitor that yields insightful data in minutes.

CathWorks Announces $30M in New Financing

DateJan 07 2021

CathWorks reported the completion of a $30 million Series D financing round. Proceeds from the financing will be used to expand commercialization of the company's FFRangio system.